全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Citrobacter koseri Infective Endocarditis in an Immunocompetent Male Successfully Treated with Valve Replacement and a Shortened-Course of Antimicrobial Therapy: A Case Report

DOI: 10.4236/aid.2025.152028, PP. 368-375

Keywords: Antimicrobial Treatment, Citrobacter koseri, Native Valve Infective Endocarditis, Mitral Valve Replacement

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Citrobacter koseri is a rare cause of infective endocarditis (IE), especially in immunocompetent individuals. We present a case of acute IE of the native mitral valve caused by C. koseri in a 61-year-old Filipino man successfully treated with valve replacement and shortened-course of antimicrobial therapy. Case Presentation: The patient presented with fever, delirium, cardiac symptoms, leukocytosis and elevated procalcitonin. He was given meropenem and vancomycin as empiric therapy, Blood cultures identified C. koseri. A transesophageal echocardiogram confirmed the presence of a large, mobile vegetation measuring 1.399 cm attached to the anterior mitral valve leaflet. Given the patient’s multiple risk factors for embolization, including a vegetation size greater than 10 mm, vegetation mobility, vegetation location on the anterior mitral valve leaflet, and the possibility of prior embolization, the patient underwent a successful valve replacement. Vegetation attached to the anterior mitral valve leaflet was visualized intraoperatively. There was no paravalvular extension of infection, annular abscess, or destructive penetrating lesion (fistula). Postoperatively, fever lysed, and inflammatory markers improved. Postoperative blood cultures were sterile. Cultures of the excised anterior mitral valve leaflet were negative for bacterial growth, likely due to the targeted antimicrobial therapy administered before surgery. Following a series of therapies, the patient was discharged with a three-week course of continuous intravenous meropenem therapy to complete the treatment regimen. The decision to shorten the treatment duration for C. koseri bacteremia from the usual six weeks for non-surgical IE was based on the removal of the infection source and the absence of any residual infection in the surrounding heart valve structures as observed during surgery. Three subsequent monthly follow-ups revealed persistently negative blood cultures, indicating the successful eradication of the infection. Discussion: Studies proposed shortening to 2 weeks for negative valve cultures revealed low incidence of relapse following surgical intervention, occurring only 0.8% of cases. Relapse, occurred in 2% of patients. No significant differences in relapse rates, 1-year recurrence, 1-year mortality, or postoperative complications between patients receiving antibiotics for more or less than two weeks. Conclusion: We report the successful management of a rare case of acute

References

[1]  Dzeing-Ella, A., Szwebel, T.A., Loubinoux, J., Coignard, S., Bouvet, A., Le Jeunne, C., et al. (2009) Infective Endocarditis Due to Citrobacter koseri in an Immunocompetent Adult. Journal of Clinical Microbiology, 47, 4185-4186.
https://doi.org/10.1128/jcm.00957-09
[2]  Fonton, P., Hassoun-Kheir, N. and Harbarth, S. (2024) Epidemiology of Citrobacter Spp. Infections among Hospitalized Patients: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 24, Article No. 662.
https://doi.org/10.1186/s12879-024-09575-8
[3]  Sharma, D., Sulaiman, Z.I., Tu, P.J., Harrelll, S., et al. (2024) A Case of Infective Endocarditis Caused by Citrobacter koseri: Unraveling a Rare Pathogen and Dire Outcome. Journal of Investigative Medicine High Impact Case Reports, 12, 1-4.
https://doi.org/10.1177/23247096241239544
[4]  Casallas-Barrera, J.O., Poveda-Henao, C.M., Mantilla-Viviescas, K.A. and Silva-Monsalve, E. (2024) Infective Endocarditis Due to Citrobacter koseri Following Testicular Trauma: Case Report and Literature Review. Therapeutic Advances in Infectious Disease, 11, 1-5.
https://doi.org/10.1177/20499361241237617
[5]  Falcone, M., Tiseo, G., Durante-Mangoni, E., Ravasio, V., Barbaro, F., Ursi, M.P., et al. (2018) Risk Factors and Outcomes of Endocarditis Due to Non-Hacek Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort. Antimicrobial Agents and Chemotherapy, 62, e02208-17.
https://doi.org/10.1128/aac.02208-17
[6]  Morris, A.J., Drinković, D., Pottumarthy, S., MacCulloch, D., Kerr, A.R. and West, T. (2005) Bacteriological Outcome after Valve Surgery for Active Infective Endocarditis: Implications for Duration of Treatment after Surgery. Clinical Infectious Diseases, 41, 187-194.
https://doi.org/10.1086/430908
[7]  Kim, J., Kim, J.H., Lee, H.J., Lee, S.J., Kim, C., Lee, J.A., et al. (2023) Impact of the Duration of Postoperative Antibiotics on the Prognosis of Patients with Infective Endocarditis. Antibiotics, 12, Article 173.
https://doi.org/10.3390/antibiotics12010173
[8]  Morris, A.J., Drinković, D., Pottumarthy, S., MacCulloch, D., Kerr, A.R. and West, T. (2005) Bacteriological Outcome after Valve Surgery for Active Infective Endocarditis: Implications for Duration of Treatment after Surgery. Clinical Infectious Diseases, 41, 187-194.
https://doi.org/10.1086/430908

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133